NCT04422132View on ClinicalTrials.gov

Randomized Phase II Trial of Salvage Radiotherapy for Prostate Cancer In 4 Weeks v. 2 Weeks

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

September 24, 2020

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2028

Conditions
Prostate Cancer
Interventions
RADIATION

5 days Radiation Therapy (32.5 Gy in 5 fractions)

Patients will receive treatment to the prostate fossa +/- nodes in either 32.5 Gy in 5 fractions or 55 Gy in 20 fractions.

RADIATION

20 days Radiation therapy (55 Gy in 20 fractions)

Patients will receive treatment to the prostate fossa +/- nodes in either 32.5 Gy in 5 fractions or 55 Gy in 20 fractions.

Trial Locations (1)

10065

Weill Cornell Medicine, New York

All Listed Sponsors
collaborator

Viewray Inc.

INDUSTRY

lead

Weill Medical College of Cornell University

OTHER